European Urology

European Urology

Volume 56, issue 3, pages 407-582, September 2009

Viewing articles 11-20 of 41


topReviews

  Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence? Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence?

Christian Seitz, Evangelos Liatsikos, Francesco Porpiglia, Hans-Göran Tiselius, Ulrike Zwergel.

19 June 2009 | pages 455 - 471

Abstract Full Text Full-Text PDF (1,0 MB) Create Platinum Slide Series

topSurgery in Motion

  Periurethral Suspension Stitch During Robot-Assisted Laparoscopic Radical Prostatectomy: Description of the Technique and Continence Outcomes Periurethral Suspension Stitch During Robot-Assisted Laparoscopic Radical Prostatectomy: Description of the Technique and Continence Outcomes

Vipul R. Patel, Rafael F. Coelho, Kenneth J. Palmer, Bernardo Rocco.

16 June 2009 | pages 472 - 478

Abstract Full Text Full-Text PDF (449 KB) Activate Visual Create Platinum Slide Series

Online Extra


topProstate Cancer

  Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy

Dominique Helley, Eugeniu Banu, Abdelkader Bouziane, Adela Banu, Florian Scotte, Anne-Marie Fischer, Stéphane Oudard.

20 June 2008 | pages 479 - 485

Abstract Full Text Full-Text PDF (500 KB) Create Platinum Slide Series

Editorial Comment on: Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy

Antonio Lopez-Beltran. Rodolfo Montironi.

pages 484 - 485

Full Text Full-Text PDF (3,6 MB)

  Mutations in the Gene in Advanced Prostate Cancer Mutations in the AXIN1 Gene in Advanced Prostate Cancer

George W. Yardy, David C. Bicknell, Jennifer L. Wilding, Sylvia Bartlett, Ying Liu, Bruce Winney, Gareth D.H. Turner, Simon F. Brewster, Walter F. Bodmer.

23 May 2008 | pages 486 - 494

Abstract Full Text Full-Text PDF (701 KB) Create Platinum Slide Series

Editorial Comment on: Mutations in the AXIN1 Gene in Advanced Prostate Cancer

Jack A. Schalken.

page 494

Full Text Full-Text PDF (89 KB)

topBladder Cancer

  Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study eulogo1

Andreas Böhle, Herbert Leyh, Christian Frei, Michael Kühn, Reinhold Tschada, Tobias Pottek, Walter Wagner, Helmut H. Knispel, Wolfgang von Pokrzywnitzki, Ferruh Zorlu, Karin Helsberg, Birgit Lübben, Victoria Soldatenkova, Clemens Stoffregen, Hartwig Büttner, on behalf of the S274 Study Group.

19 June 2009 | pages 495 - 503

Abstract Full Text Full-Text PDF (535 KB) Create Platinum Slide Series

EU*ACME


topUrothelial Cancer

  Topical Chemotherapy in Human Urothelial Carcinoma Explants: A Novel Translational Tool for Preclinical Evaluation of Experimental Intravesical Therapies Topical Chemotherapy in Human Urothelial Carcinoma Explants: A Novel Translational Tool for Preclinical Evaluation of Experimental Intravesical Therapies

Christian Bolenz, Eva-Maria Ikinger, Philipp Ströbel, Lutz Trojan, Annette Steidler, Mario I. Fernández, Patrick Honeck, Ute Gabriel, Christel Weiss, Rainer Grobholz, Peter Alken, Maurice Stephan Michel.

30 July 2008 | pages 504 - 511

Abstract Full Text Full-Text PDF (853 KB) Create Platinum Slide Series

  The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed? The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed? eulogo1

Marco Roscigno, Shahrokh F. Shariat, Vitaly Margulis, Pierre Karakiewicz, Mesut Remzi, Eiji Kikuchi, Richard Zigeuner, Alon Weizer, Arthur Sagalowsky, Karim Bensalah, Jay D. Raman, Christian Bolenz, Wassim Kassou, Theresa M. Koppie, Christopher G. Wood, Jeffrey Wheat, Cord Langner, Casey K. Ng, Umberto Capitanio, Roberto Bertini, Mario I. Fernández, Shuji Mikami, Masaru Isida, Philipp Ströbel, Francesco Montorsi.

18 June 2009 | pages 512 - 519

Abstract Full Text Full-Text PDF (336 KB) Create Platinum Slide Series

EU*ACME


Editorial Comment on: The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?

Guido Dalbagni.

18 June 2009 | page 519

Full Text Full-Text PDF (65 KB)

Viewing articles 11-20 of 41


Listing options

Free Content

Top 10 cited